Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oncovite is a high-potency multivitamin and mineral supplement developed by Mission Pharmacal, specifically formulated for urologic health. The product's composition was based on clinical research, notably by Dr. Charles Lamm, which investigated the role of specific vitamins and minerals in reducing the recurrence of superficial bladder cancer. The formulation typically includes high doses of Vitamin A, Vitamin C, Vitamin E, Vitamin B6, and Zinc. While marketed as a dietary supplement, it is frequently recommended by urologists as a supportive therapy for patients with bladder cancer, particularly those undergoing Bacillus Calmette-Guérin (BCG) therapy, to enhance immune response and provide antioxidant protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oncovite.